The role of self-efficacy and medication adherence in linking personality traits to health-related quality of life in middle-aged and older patients with chronic diseases Authors: Jinyu He, Siyuan Liu, Yiran Wang, Huatang Zeng, Chenyu Yan, Wannian Liang Published: 2026 ABSTRACT AbstractObjectiveImproving the health-related quality of life of individuals with chronic diseases is a key goal in chronic disease management. However, limited research has examined how personality traits influence health-related quality of life in this population. This study aimed to develop a unified model to investigate the mediating roles of self-efficacy and medication adherence in the relationship between personality traits and health-related quality of life among middle-aged and older adults with chronic diseases.MethodsData were obtained from the 2021 Psychology and Behavior Investigation of Chinese Residents (PBICR), a multi-center, cross-sectional survey conducted in 120 cities across 22 provinces in China. The final analytic sample included 1,037 patients aged 45 and older who had been diagnosed with chronic diseases and were on medication. Standardized instruments were used to measure Big Five personality traits (10-item Big Five Inventory, BFI-10), self-efficacy (General Self-Efficacy Scale, GSES), medication adherence (Medication Adherence Report Scale, MARS), and health-related quality of life (EuroQol 5-Dimension 5-Level questionnaire, EQ-5D-5 L). Structural equation modeling (SEM) was used to test the serial mediating roles of self-efficacy and medication adherence in the association between personality traits and health-related quality of life.ResultsThe findings indicated that several personality traits, particularly Conscientiousness, Extraversion, and Neuroticism, were significantly associated with health-related quality of life. Self-efficacy and medication adherence sequentially mediated the relationship between personality traits and health-related quality of life. The proposed structural equation modeling showed good model fit (CFI = 0.996; RMSEA = 0.002), and the indirect effects were statistically significant based on bootstrapping results.ConclusionThis study advances understanding of the associations between personality traits and health-related quality of life in chronically ill middle-aged and older adults. By identifying self-efficacy and medication adherence as sequential mediators, the findings offer theoretical and practical insights for designing personalized behavioral interventions to improve health-related quality of life in this population.Supplementary InformationThe online version contains supplementary material available at 10.1186/s40359-026-04858-y.Keywords: Personality Traits, Health-Related Quality of Life, Self-Efficacy, Medication Adherence, Chronic Diseases Background The rapid aging of the global population and the increasing prevalence of chronic diseases pose significant challenges to public health worldwide [1]. In China, the burden of chronic diseases among the older adult population is particularly severe. A cross-sectional study reported that 42% of middle-aged and older (aged 45 and above) individuals had chronic conditions, with a comorbidity prevalence of 16.8% [2]. Over two decades, the prevalence of chronic diseases among older participants rose markedly from 51.8% in 1998 to 62.3% in 2018 [3]. Living with chronic conditions significantly affects health-related quality of life (HR QoL) and well-being [4]. Enhancing the QoL of this vulnerable population is critical not only for improving individual well-being but also for mitigating the societal and economic burdens associated with chronic diseases [4]. In China, with the release of a series of policies to promote the health of the whole population, such as the “Healthy China 2030” Plan Outline, which emphasizes the promotion of health literacy and the improvement of population health and quality of life. In this context, understanding the determinants of HR QoL among middle-aged and older patients with chronic diseases is both academically and practically important. While clinical interventions remain crucial, the psychosocial factors influencing HR QoL warrant deeper exploration to develop comprehensive, patient-centered care strategies [5]. Personality traits, as stable and enduring characteristics, shape individuals’ cognition, behavior, and coping mechanisms in the face of health challenges [6]. The Five-Factor Model is widely recognized as an adequate conceptualization of the structure of personality traits, which is believed to capture, to a reasonable extent, the variation in personality characteristics across individuals [7]. Traits such as Conscientiousness and Neuroticism are particularly relevant in the context of chronic disease management, influencing health behaviors, coping strategies, and interactions with healthcare systems [8, 9]. For example, Conscientiousness is associated with disciplined health behaviors [5], whereas Neuroticism may exacerbate stress and maladaptive coping, potentially diminishing HR QoL [10]. Among the various personality theories, the Five-Factor Model (FFM) has emerged as the most widely accepted and empirically validated framework for understanding personality in health-related research. Despite these established associations, how personality traits are associated with HR QoL, particularly among individuals with chronic diseases, remains inadequately understood. Therefore, the current research focuses in particular on Conscientiousness and Neuroticism. One important pathway through which personality traits may influence HR QoL is via individual behavioral and psychological processes. Self-efficacy, generally defined as an individual’s belief in their capacity to execute behaviors necessary to achieve desired outcomes, serves as a key mediating factor in the relationship between personality traits and health outcomes [11]. Higher self-efficacy is linked to better chronic disease management and greater adherence to prescribed treatments [12]. Similarly, medication adherence, a critical determinant of disease control and progression, is influenced by both personality traits and self-efficacy [13]. Existing studies on HR QoL in chronic disease populations have mainly concentrated on clinical characteristics and sociodemographic correlates, whereas psychosocial factors have received comparatively less systematic attention. In particular, personality traits, self-efficacy, and medication adherence have often been examined separately or within single mediation models, which limits understanding of how psychological traits may influence HR QoL through downstream behavioral processes. Without an integrated framework, it remains difficult to clarify how relatively stable personality traits are associated with proximal cognitive factors and health behaviors, all of which are jointly associated with HR QoL. Moreover, evidence from Chinese middle-aged and older chronic disease populations remains limited. Against this backdrop, few studies have examined whether self-efficacy and medication adherence operate as serial mediators in the relationship between personality traits and HR QoL. This study aims to address this gap by exploring these pathways in middle-aged and older patients with chronic diseases. We strive to provide actionable insights for the development of targeted interventions that can enhance HR QoL for this vulnerable population. The study seeks to answer the following research questions: (1). How do personality traits influence the quality of life among middle-aged and older patients with chronic diseases? (2). What role does self-efficacy play in mediating the relationship between personality traits and HR QoL? (3)How does medication adherence act as a further mediator in this relationship, and what are the implications of its sequential interplay with self-efficacy? Understanding the pathways through which personality traits influence HR QoL is critical for designing targeted interventions that address not only the physiological aspects of chronic disease management but also the psychological and behavioral dimensions [14]. Self-efficacy, as a central concept in health psychology, reflects an individual’s belief in their ability to manage different tasks and challenges, including health-related behaviors and expectations for good health outcomes [15]. Its influence on health behaviors, including medication adherence, is well-documented [16]. However, despite these established links, several important gaps remain. Most existing studies have either examined personality traits, self-efficacy, or medication adherence in isolation or considered only single mediation models. There is a lack of integrated frameworks that examine how psychological and behavioral factors may sequentially mediate the relationship between personality and HR QoL. Examining the interplay of these variables within a serial mediation framework offers a more nuanced understanding of the complex dynamics at work. By integrating personality traits, self-efficacy, and medication adherence into a serial mediation model, this study advances theoretical understanding of the psychosocial determinants of HR QoL. It also provides a foundation for the design of targeted interventions aimed at improving HR QoL among middle-aged and older patients with chronic diseases. Literature and theory Personality traits and quality of life The relationship between personality traits and quality of life has garnered considerable attention in the fields of psychology and health sciences [5, 6]. Personality traits are usually defined by the Big Five framework, namely Openness, Conscientiousness, Extraversion, Agreeableness, and Neuroticism, and they serve as fundamental determinants of individual behavior, cognition, and emotion [17]. Among these traits, Conscientiousness has consistently been a robust predictor of positive health behaviors and the improvement of health conditions [5, 6]. Highly conscientious individuals tend to engage in disciplined health management practices, including adhering to prescribed treatment plans and actively seeking medical services [18]. Additionally, the goal-oriented behavior and self-regulation associated with Conscientiousness contribute to better life outcomes and a greater sense of fulfillment, which in turn enhances their overall quality of life [18]. Individuals with extroverted traits generally exhibit more positive emotional experiences and engage in more frequent and fulfilling social interactions, ultimately contributing to an enhanced sense of overall well-being [19]. Research shows that both Openness and Agreeableness are positively linked to better HR QoL [20–22]. Openness promotes health-promoting behaviors, emotional resilience, and adaptive coping, which enhance mental health and overall well-being [21]. It is also associated with lower inflammation and higher energy levels during physical activities [21]. Agreeableness, marked by traits like cooperativeness and tolerance, fosters supportive social networks and better social relationships [22], which improve psychological health and life satisfaction [23]. Conversely, Neuroticism, characterized by heightened emotional instability, anxiety, and vulnerability to stress, is closely associated with adverse health outcomes, including increased psychological distress, somatic complaints, lower life satisfaction [5] and a decline in HR QoL [24]. In the context of chronic diseases, these relationships become particularly prominent. Chronic diseases often impose substantial psychological, physical, and social burdens, which require individuals to adopt adaptive coping mechanisms and demonstrate resilience [25]. Personality traits not only influence how individuals perceive and respond to their own diseases but also affect how they cope with challenges and maintain social relationships [26], all of which are key components of HR QoL. Some studies have found that the Extraversion personality trait can help build robust social support networks, thereby buffering the emotional and social pressures brought about by chronic diseases [27]. On the other hand, Neuroticism may amplify the perceived stressors and hinder effective coping strategies, thus exacerbating the negative impact of chronic diseases on HR QoL [28]. Research has also examined the roles of Openness and Agreeableness in the context of chronic diseases. Although their impacts are less significant compared with Extraversion and Neuroticism in most research, both of them can also create a robust framework for coping with the challenges posed by chronic illnesses which has a positive effect on HR QoL [5, 29]. Although the existing literature has clearly confirmed the importance of personality traits in shaping HR QoL [30], there is a lack of discussion on the underlying associations [31]. Emerging evidence highlights the importance of incorporating mediating variables into the personality-HR QoL model [31]. A longitudinal study demonstrated that Conscientiousness can predict better physical health and a lower mortality risk within a decade through consistent health-promoting behaviors [20]. Another study found that Neuroticism can significantly predict worse HR QoL among patients with cardiovascular diseases, mainly through its impact on perceived stress and maladaptive coping [32]. Research on Extraversion and Agreeableness has also highlighted their indirect contributions to HR QoL through social support [33]. These studies further emphasize the importance of analyzing the mediating factors related to personality and HR QoL, providing practical intervention measures for improving the HR QoL of middle-aged and older patients with chronic diseases. Therefore, the current study proposes to examine both direct and indirect pathways from personality traits to HR QoL, beginning with the direct associations as stated in Hypothesis 1. H1: Different personality traits, particularly Conscientiousness and Neuroticism, are significantly associated with the HR QoL of middle-aged and older patients with chronic diseases. Mediating effect of self-efficacy Self-efficacy, defined as the belief in one’s ability to execute actions required to achieve specific outcomes, is a central construct in health psychology [34]. According to Social Cognitive Theory, individuals’ beliefs in their own capabilities play a central role in how they approach goals, challenges, and tasks [35]. In this framework, self-efficacy is regarded as a proximal determinant of health behavior, influencing whether individuals initiate and sustain treatment-related actions. The Self-Regulation Theory [36] enhances the understanding of how self-efficacy interacts to influence health behaviors. This theory emphasizes the role of self-monitoring, goal-setting, and behavioral adjustment in health management. Chronic disease patients need to monitor their symptoms and adjust their behaviors in response to changes in their health. In this process, self-efficacy is crucial. Individuals with higher self-efficacy are more likely to maintain health-promoting behaviors and achieve better health outcomes [37]. To explore the behavioral pathways linking self-efficacy to medication adherence, we draw on established theoretical models and empirical findings. In the context of chronic disease management, self-efficacy is critical, as patients’ confidence in their ability to manage their health significantly impacts their health behaviors, including medication adherence. Medication adherence, or the extent to which patients take medications as prescribed, is a cornerstone of effective chronic disease management [38]. Non-adherence, whether due to forgetfulness, side effects, or psychological resistance, undermines treatment efficacy and contributes to disease progression, increased healthcare costs, and reduced HR QoL [38, 39]. The World Health Organization identifies non-adherence as a global challenge, particularly in chronic disease populations where long-term treatment regimens are the norm [40].The Health Belief Model [41] provides further insight into how self-efficacy influences medication adherence. The model suggests that individuals’ decisions to engage in health behaviors are influenced by their perceptions of the severity of their illness, the perceived benefits of the behavior, and the barriers to taking action. In this framework, self-efficacy reflects patients’ confidence in their ability to overcome barriers and adhere to prescribed treatment. Patients who believe they can effectively manage their condition are more likely to recognize the benefits of adherence and translate these beliefs into actual medication-taking behavior. As a result, their self-efficacy directly affects their adherence behavior, thereby influencing their health outcomes [42]. Self-efficacy does not function in isolation; it is shaped by personality traits, which influence individuals’ emotional responses. Different personality characteristics may correspond to varying levels of self-efficacy [43]. A meta-analytic review indicated that lower levels of Neuroticism and higher levels of Extraversion, Openness to experience, Agreeableness, and Conscientiousness were positively associated with greater generalized self-efficacy [44]. The Big Five Personality Traits have also been shown to significantly impact health-related behaviors. Positive individuals, with their propensity for planning and self-discipline, are more likely to adhere to prescribed treatments [45, 46]. Studies have found that chronic disease patients with higher levels of Conscientiousness tend to have more structured self-management plans. Openness encourages exploration and cognitive flexibility, which enhances problem-solving skills and creativity—both crucial components of self-efficacy [47, 48]. Research has indicated that high levels of Extraversion correlate positively with self-efficacy, as extraverts generally exhibit more confidence in their social skills and are motivated to assert themselves in various scenarios [49]. Agreeableness, which reflects kind and cooperative traits, contributes to self-efficacy through the formation of positive social relationships and supportive environments [50]. Patients who score higher on traits such as Agreeableness or Openness may demonstrate more adaptive coping strategies, which can buffer the negative effects of chronic diseases and enhance their ability to manage their condition [4, 5, 8].Conversely, Neuroticism has been shown to undermine self-efficacy and reduce self-management capabilities. Individuals high in Neuroticism may struggle with medication adherence due to heightened anxiety or concerns about potential side effects [45, 46]. H2: Self-efficacy mediates the association between personality traits (particularly Conscientiousness and Neuroticism) and medication adherence, as part of a sequential pathway toward health-related quality of life. Mediating effect of medication adherence Patients with higher self-efficacy are more likely to follow prescribed treatments, engage in health-promoting behaviors, and persist in managing their chronic conditions despite obstacles. Conversely, patients with lower self-efficacy may struggle to adhere to treatment regimens, which can result in poorer health outcomes and a decline in HR QoL [51]. Research has shown that adherence to prescribed medications significantly enhances health-related quality of life among patients with chronic conditions [52]. Specifically, greater medication adherence has been associated with reduced hospitalizations and emergency department visits, which are crucial factors in maintaining a higher overall quality of life for these individuals [53]. From a health psychology perspective, self-efficacy is more likely to precede medication adherence because it reflects patients’ confidence in managing their illness, whereas adherence represents the behavioral enactment of such confidence. H3: Medication adherence mediates the association between self-efficacy and HR QoL. Personality traits significantly influence adherence behaviors. These behavioral tendencies are often mediated by psychological factors [45]. The literature also demonstrates that medication adherence is associated with health outcomes and HR QoL [54]. Based on the theoretical framework and the literature review, this study aims to test a serial mediation model to explore the relationships between personality traits, self-efficacy, medication adherence, and quality of life among middle-aged and older patients with chronic diseases. Importantly, self-efficacy may be theoretically positioned as an upstream cognitive factor that is associated with personality traits on one hand and with medication adherence on the other, with adherence further associated with HR QoL. The cross-sectional data, however, do not permit causal or temporal interpretations. Thus, rather than operating merely as independent mediators, self-efficacy and medication adherence may form a sequential pathway linking personality traits to HR QoL. H4: Personality traits influence HR QoL through both direct and indirect paths, with self-efficacy and medication adherence functioning as sequential mediators. These hypotheses aim to integrate personality traits, self-efficacy, and medication adherence into a comprehensive framework for understanding their associations with HR QoL.The hypothesized sequential pathway from personality traits to self‑efficacy, then to medication adherence, and finally to HR QoL is theoretically grounded in prior longitudinal and experimental studies. However, given the cross‑sectional design of the present study, this model should be viewed as a theory‑based statistical representation of associations, not as evidence of temporal ordering or causation. Testing this serial mediation model will provide actionable insights for designing targeted interventions to improve HR QoL among middle-aged and older patients with chronic diseases (Framework in Fig. 1). Study framework. Note: HR QoL Health-Related Quality of Life Methods Study participants The data for this study was sourced from the 2021 Psychology and Behavior Investigation of Chinese Residents (PBICR), a large-scale, multi-center cross-sectional survey designed to capture comprehensive and representative data on the psychosocial and behavioral characteristics of Chinese residents. The survey was carried out from June to August in 2021 and collected feedback information from residents in 120 cities across 22 provinces. Trained interviewers conducted face-to-face interviews to conduct the survey and recorded the survey results on “Questionnaire Star”, an online survey tool widely used in China. The whole process ensured the anonymity of the participants, and all participants had signed the informed consent forms. More information regarding the methodology of the Psychology and Behavior Investigation of Chinese Residents (PBICR) can be found in other materials [55]. The 2021 PBICR had already passed the ethical reviews of the Shaanxi Provincial Health Culture Research Center (JKWH-2021-01) and Jinan University (JNUKY-2021-018). Informed consent to participate in the study has been obtained from all participants of this project. The total sample size publicly available after weighting and cleaning in the PBICR project in 2021 was 11,031. Among them, the number of samples aged 45 and above was 3,365 people. After retaining 2,046 samples of those with chronic diseases (including hypertension, diabetes, cardiovascular diseases, liver and kidney diseases, and lung diseases) and deleting the samples of those who did not adhere to taking medications or did not take medications, the number of samples finally included in the analysis was 1,037 participants. The sample size was determined based on SEM guidelines for observed-variable models. Our model includes 48 parameters (30 path coefficients, 15 variances/covariances of exogenous variables, and 3 residual terms of endogenous variables). A conservative 15:1 participant-to-parameter ratio [56] requires a minimum of 720 participants, and 200 cases are the baseline for stable estimations. Our final sample of 1,037 participants (around 21.6:1 ratio) far exceeds these requirements, ensuring adequate power and reliability of model estimates. Measures Health-related quality of life (HR QoL) We used the European HR QoL Five-Dimensional Questionnaire 5-Level Version (EQ-5D-5 L) to assess the HR QoL of patients with chronic diseases. The EQ-5D-5 L is a tool commonly used for evaluating health-related quality of life. The scale includes five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Compared with the EQ-5D-3 L version, the EQ-5D-5 L has a more refined grading setting in terms of describing health states and other aspects, and can measure individual health-related situations more accurately [57]. We use the data of the European HR QoL EQ-5D-5 L version and evaluate the health programs and technologies in China based on the rescaled values predicted by the 8-parameter model. This method is based on the parsimony criterion and uses cross-validation to provide a basis for model estimation, and it has a high level of face validity [58]. A health-related quality of life score with a value ranges from − 0.39 to 1.00 was generated. Big five personality Personality traits were measured using the 10-item short version of the Big Five Inventory (BFI-10) developed by Gosling and Rentfrow [59]. The BFI-10 has been widely used and has a high degree of correlation and internal consistency with the BFI-30. This scale includes five dimensions: Openness, Conscientiousness, Extraversion, Agreeableness and Neuroticism. It adopts a 5-point Likert scale scoring method ranging from “1 = strongly disagree” to “5 = strongly agree”. The higher the score, the more obvious the personality tendency is. BFI-10 has shown good reliability and validity in investigation across China [60]. In this study, the Cronbach’s alpha coefficient ranges between 0.68 and 0.71, composite reliability ranges between 0.68 and 0.72, average variance extracted ranges between 0.51 and 0.59. Self-efficacy Self-efficacy was measured using the General Self-Efficacy Scale (GSES) developed by Schwarzer (1995). This scale consists of 8 items and adopts a 4-point scoring system. The larger the value, the more agreement it indicates. The total score is calculated by adding up the scores of all items, and the higher the total score, the higher the level of self-efficacy. The scale has undergone cross-cultural adaptation adjustments and its reliability and validity have been further corroborated by studies using the PBICR dataset. In this study, the Cronbach’s α coefficient of this scale was 0.93, composite reliability is 0.93, average variance extracted is 0.62. Medication adherence The Medication Adherence Rating Scale (MARS) was used to measure the medication adherence of patients with chronic diseases [61]. The Medication Adherence Rating Scale is a ten-item yes/no self-reporting tool. It was developed based on two existing scales, namely the 30-item Drug Attitude Inventory (DAI) [62] and the 4-item Medication Adherence Questionnaire (MAQ) [63], with the aim of developing a more reliable and effective tool to assess medication adherence behavior. The Chinese version of the MARS has been previously adapted and applied in studies involving Chinese patients with chronic illnesses [64]. The total score ranges from 0 (low medication adherence) to 10 (high medication adherence). In this study, the Cronbach’s α coefficient of this scale was 0.68, composite reliability is 0.68, average variance extracted is 0.50. Covariates All analyses incorporated the basic demographic covariates, namely age groups (middle-aged, young-old, and old-old), gender (male and female), place of household registration (urban and rural), and marital status (married and unmarried). To explore the role of socioeconomic status and health-related covariates in the serial mediation, we additionally included years of education, per capita monthly household income, and obesity status in the analyses. In addition, considering the care issues of patients with chronic diseases, we controlled for the number of children. Data analysis SEM were employed to measure the mediating effects of self-efficacy and medication adherence in the correlation between middle-aged and older patients with chronic diseases and their HR QoL. This study employed covariance-based Structural Equation Modeling to test the hypothesized model. This method is suitable for validating and refining models based on strong theoretical priors and aligns well with the objective of our study. Discriminant validity was assessed using the Fornell-Larcker criterion. The results showed that the square root of the AVE for all latent variables (diagonal elements) was greater than their correlations with other latent variables (off-diagonal elements), indicating adequate discriminant validity among the constructs (Table S1 of the supplementary materials). Firstly, multiple linear regression was utilized to evaluate the correlations among personality and self-efficacy, self-efficacy and medication adherence, medication adherence and HR QoL, as well as personality and HR QoL, generating both adjusted and unadjusted models. We chose multiple linear regression to verify the correlations among variables instead of zero-order correlations. This is because linear regression can simultaneously present the results of both the unadjusted and adjusted models, and the results are more robust. To enable readers to comprehensively understand the simple associations among variables, we have also listed the results of zero-order correlations in Table S2 of the supplementary materials. Subsequently, Structural Equation Models were used to estimate the mediating effects of self-efficacy and medication adherence. Given the influence among different personality traits, all personality traits were incorporated into the models for analysis. To evaluate the model fit, we relied on a set of widely recognized fit indices. The chi-square statistic (X2) and its ratio to degrees of freedom (X2/df < 3) were used to indicate the acceptable level of model fit. Meanwhile, the Comparative Fit Index (CFI > 0.90) and the Root Mean Square Error of Approximation (RMSEA < 0.08) were adopted to represent the degree of model fit [56, 65]. Use the bootstrap (with 500) method to test the robustness of the coefficients in the structural equation model, and obtain the estimates, standard errors and confidence intervals of each coefficient based on the bootstrap method. An indirect effect was considered statistically significant if its confidence interval did not include zero. The standardized coefficients were presented. The significance of the correlation was examined using a two-tailed test, p < 0.05 was statistically significant. All analyses were performed using Stata 18.0 (Stata Corporation, College Station, TX, U.S.A.). Result Descriptive characteristics of the study participants Table 1 shows the basic characteristics of the samples, with a total of 1037 participants. Males accounted for 55.26% and females accounted for 44.74%. 46.48% of the participants were middle-aged people, 41.27% were young-old people, and 12.25% were old-old people. 41.37% of the participants were from rural areas, 83.22% of the samples were currently married, and the average years of education were 10.527 (SD = 4.912). 42.33% of the samples were diagnosed as obese. The overall HR QoL of the participants was at a relatively high level (Mean = 0.886, SD = 0.167). The scores of each dimension of the Big Five personality traits were relatively balanced. The score of Conscientiousness was the highest (Mean = 7.208, SD = 1.609), while the score of Neuroticism was the lowest (Mean = 5.702, SD = 1.451). The overall self-efficacy was at a relatively good level (Mean = 20.607, SD = 5.101), and the medication adherence was at an average level (Mean = 5.699, SD = 2.198). There are statistically significant differences in the HR QoL between gender groups. For the Big Five personality traits, there are statistically significant differences in Conscientiousness and Extraversion between gender groups. There are significant differences in the HR QoL among all covariate groups. Table 1Basic information about individualsVariableCategoryComplete Sample (N = 1037)statistic pOutcome HR QoLMSD0.8860.1670.043*Predictor OpennessMSD6.0401.5130.087 ConscientiousnessMSD7.2081.609< 0.001*** ExtraversionMSD6.1621.5760.029* AgreeablenessMSD6.9471.4660.239 NeuroticismMSD5.7021.4510.138Mediators Self-efficacyMSD20.6075.1010.229 Medication AdherenceMSD5.6992.1980.341Covariates Age groupsMiddle-aged people482(46.48%)< 0.001***Young-old people428(41.27%)Old-old people127(12.25%)GenderFemale464(44.74%)Male573(55.26%)Household registrationRural429(41.37%)< 0.001***Urban608(58.63%)MarriageCurrently not in marriage174(16.78%)0.008Currently in marriage863(83.22%)Number of children064(6.17%)< 0.001***1409(39.44%)2383(36.93%)≥ 3181(17.45%)EducationMSD10.5274.912< 0.001***Per capita monthly household income (Yuan)MSD4967.9363427.07< 0.001***ObesityYes439(42.33%)0.038*No598(57.67%)Continuous variables are presented in terms of means and standard deviations, and categorical variables are shown using percentages and sample sizes. The statistical P-values of outcome, predictor, and mediator variables represent the gender differences tested by the T-test. Covariates pertain to the differences in HR QoL scores among groups. For continuous variables, relevant R values are provided; for dummy variables, chi-square test results are given; and for multi-classification variables, analysis of variance statistics are presented. *p < 0.05, **p < 0.01,***p < 0.001 Basic information about individuals Continuous variables are presented in terms of means and standard deviations, and categorical variables are shown using percentages and sample sizes. The statistical P-values of outcome, predictor, and mediator variables represent the gender differences tested by the T-test. Covariates pertain to the differences in HR QoL scores among groups. For continuous variables, relevant R values are provided; for dummy variables, chi-square test results are given; and for multi-classification variables, analysis of variance statistics are presented. *p < 0.05, **p < 0.01,***p < 0.001 The correlations among HR QoL, personality traits, self-efficacy and medication adherence Both the models prior to and after adjustment indicate that significant positive associations exist between Openness, Conscientiousness, Extraversion, and Agreeableness and self-efficacy (with coefficients of 0.343, 0.813, 0.340, and 0.460 respectively before adjustment, p < 0.001). In contrast, Neuroticism exhibits a significant negative association with self-efficacy (with a coefficient of -0.492 before adjustment, p < 0.001). Moreover, the positive relationships between Extraversion and Agreeableness and medication adherence are relatively stable. Likewise, both the models before and after adjustment reveal that significant positive associations are present between Conscientiousness, Extraversion and HRQoL (with coefficients of 0.007 and 0.008 respectively before adjustment, p < 0.05), while Openness and Neuroticism demonstrate a significant negative association with HRQoL (with coefficients of -0.005 and − 0.008 respectively before adjustment, p < 0.05). Additionally, self-efficacy has significant positive associations with both medication adherence (β = 0.084 before adjustment, p < 0.001) and HRQoL (β = 0.005 before adjustment, p < 0.001), and a significant positive association also exists between medication adherence and HRQoL (β = 0.010 before adjustment, p < 0.001). For the complete table, please refer to Table S3 in the supplementary materials. Table 2Correlation analysis among the big five personality traits, self-efficacy, medication adherence and quality of lifeSelf-efficacyMedication AdherenceHR QoLUnadjusted ModelAdjusted ModelUnadjusted ModelAdjusted ModelUnadjusted ModelAdjusted ModelOpenness0.343***0.264**0.0610.033-0.005*-0.008*[0.148,0.538][0.067,0.462][-0.025,0.147][-0.055,0.122][-0.011,-0.001][-0.014,-0.001]Conscientiousness0.813***0.831***0.094*0.0900.007*0.008*[0.614,1.012][0.632,1.029][0.004,0.184][-0.000,0.180][0.001,0.014][0.002,0.014]Extraversion0.340***0.351***0.092*0.096*0.008*0.008**[0.156,0.525][0.169,0.533][0.006,0.179][0.010,0.183][0.002,0.014][0.002,0.014]Agreeableness0.460***0.416***0.152**0.135**0.009*0.005[0.242,0.677][0.192,0.640][0.054,0.250][0.037,0.234][0.002,0.017][-0.002,0.012]Neuroticism-0.492***-0.497***-0.069-0.041-0.008*-0.009**[-0.702,-0.281][-0.712,-0.283][-0.162,0.024][-0.132,0.051][-0.014,-0.002][-0.016,-0.003]Self-efficacy0.084***0.077***0.005***0.004*[0.058,0.110][0.050,0.103][0.002,0.008][0.001,0.006]Medication Adherence0.010***0.010***[0.005,0.015][0.005,0.015]The adjusted model incorporated all covariates. Multiple linear regression was used to test the correlations among the Big Five personality traits, HR QoL, self-efficacy and medication adherence. The 95% confidence intervals are shown in parentheses. *p < 0.05, **p < 0.01, ***p < 0.001 Correlation analysis among the big five personality traits, self-efficacy, medication adherence and quality of life The adjusted model incorporated all covariates. Multiple linear regression was used to test the correlations among the Big Five personality traits, HR QoL, self-efficacy and medication adherence. The 95% confidence intervals are shown in parentheses. *p < 0.05, **p < 0.01, ***p < 0.001 The structural equation model predicts the serial mediating effect Therefore, SEM was employed to test the hypothesized associations among constructs (Table 3). For the complete table, please refer to Table S4 in the supplementary materials. The model showed excellent fit, indicating good consistency between the hypothesized model and the observed data. Specifically, the chi-square value (df = 425) was 467.65, the Comparative Fit Index (CFI) was 0.996, the Tucker-Lewis Index (TLI) was 0.993, the Root Mean Square Error of Approximation (RMSEA) was 0.002 (95% CI: 0.001–0.004), and the Standardized Root Mean Square Residual (SRMR) was 0.004. Collectively, these indices indicate an excellent model fit, suggesting that the model effectively captured the hypothesized relationships. Considering the mutual influences among different personalities, we also incorporated the personalities that were not significant in the relevant regressions when establishing the structural equation model. Table 3Path coefficients estimated by the structural equation model after the bootstrap testSelf-efficacyMedication AdherenceHR QoLOpenness0.254**0.022-0.009**[0.064,0.443][-0.066,0.111][-0.016,-0.003]Conscientiousness0.828***0.0320.006[0.639,1.018][-0.059,0.124][-0.001,0.013]Extraversion0.353***0.0800.006*[0.172,0.533][-0.005,0.165][0.000,0.013]Agreeableness0.405***0.114*0.004[0.195,0.615][0.016,0.213][-0.004,0.011]Neuroticism-0.493***-0.005-0.007*[-0.694,-0.292][-0.100,0.090][-0.014,-0.000]Self-efficacy0.058***0.002[0.029,0.086][-0.000,0.004]Medicine Adherence0.007**[0.003,0.012]HR QoL Health-Related Quality of Life; The covariates have been controlled. The standardized coefficients under robust standard errors were all presented, with the 95% confidence intervals shown in parentheses. *p < 0.05, **p < 0.01, ***p < 0.001 Path coefficients estimated by the structural equation model after the bootstrap test HR QoL Health-Related Quality of Life; The covariates have been controlled. The standardized coefficients under robust standard errors were all presented, with the 95% confidence intervals shown in parentheses. *p < 0.05, **p < 0.01, ***p < 0.001 Figure 2 graphically illustrates the proposed interconnections among the variables, depicting statistically significant path coefficients. The observed path coefficients were significant, providing further evidence consistent with the hypothesized relationships within the model (based on cross-sectional data). Additionally, to determine the significance of the indirect associations, bootstrapping analyses were conducted with 1,000 resamples. Table 3 presents the path coefficients after the bootstrapping test in detail. The results of the direct, indirect, and total associations estimated by the bootstrap method are fully presented in Table S5 of the supplementary materials. Structural equation model for predicting HR QoL with the Big Five personality traits as predictor variables and self-efficacy and medication adherence as mediator variables. Note: HR QoL = Health-Related Quality of Life; Standardized coefficients are reported. Solid lines represent significant paths, and dotted lines represent non-significant paths. *p < 0.05, **p < 0.01, ***p < 0.001 The model first tests Hypothesis 1. The Openness (β= -0.009, p < 0.01), Extraversion (β = 0.006, p < 0.05) and Neuroticism (β= -0.007, p < 0.05) show direct associations with HR QoL. Regarding Hypothesis 2, we obtained the following results. The Openness (β = 0.254, p < 0.001), Conscientiousness (β = 0.828, p < 0.001), Extraversion (β = 0.353, p < 0.001) and Agreeableness (β = 0.405, p < 0.001) can all significantly and positively predict self-efficacy, while Neuroticism (β=-0.493, p < 0.001) can negatively predict self-efficacy. Self-efficacy can significantly and positively predict medication adherence (β = 0.058, p < 0.001). Different personalities were found to be associated with self-efficacy, which in turn was related to medication adherence of middle-aged and older patients with chronic diseases. Regarding Hypothesis 3, we obtained the following results. Medication adherence can positively predict the HR QoL (β = 0.007, p < 0.01). Consistent with Hypothesis 2, our results supported Hypothesis 3, suggesting that self-efficacy was positively associated with medication adherence, which in turn was related to better HR QoL among middle-aged and older patients with chronic diseases. When testing Hypothesis 4, we obtained the following results. Openness and Extraversion are significantly associated with higher self-efficacy of middle-aged and older patients with chronic diseases. In turn, higher self-efficacy was positively associated with greater medication adherence and better HR QoL. In contrast, Neuroticism was negatively associated with self-efficacy, which was further linked to lower medication adherence and HR QoL. Discussion Chronic diseases and their associated disease burdens significantly impact on the HR QoL of hundreds of millions of older people, posing an urgent challenge to achieve active aging. Medication adherence, a critical component of chronic diseases self-management, plays a vital role in mitigating the adverse outcomes associated with these chronic diseases. Self-efficacy, an important predictor of health self-management behaviors, is also closely related to personality traits. Based on these considerations, we explored the interrelationships among personality traits, self-efficacy, medication adherence, and HR QoL in middle-aged and older adults with chronic diseases. Although prior studies have examined these variables separately, few have integrated them into a unified framework to investigate the mediating roles of self-efficacy and medication adherence. By addressing this gap, our findings offer theoretical insight into the psychological correlates of HR QoL and provide practical implications for interventions aimed at improving health outcomes among aging populations with chronic conditions. The average HR QoL score of the study population was 0.890.17, which is slightly lower than the HR QoL values reported for the general Chinese population in previous research [66]. Consistent with most prior research [5, 6, 8, 9], personality traits in this study showed significant associations with HR QoL. In line with previous studies, we found that Conscientiousness and Extraversion were positive associations with higher HR QoL, while Neuroticism showed a negative association. Based on the Five-Factor Model [67, 68] and Bandura’s social cognitive theory [69], individuals with high levels of Conscientiousness tend to be organized, responsible, and self-disciplined-characteristics that facilitate adherence to health behaviors and effective self-management. Extraverted individuals typically experience greater positive affect and social engagement, and these factors, together with social support and active coping, are positively associated with perceived well-being. In contrast, those high in Neuroticism are more susceptible to negative emotions such as anxiety and stress, which can undermine psychological resilience and perceived health status. Both self-efficacy and medication adherence were also positively correlated with HR QoL [13, 14, 16], further reinforcing the robustness of existing evidence. Unlike previous studies reporting that individuals with higher levels of Openness tend to experience more favorable health outcomes [70], we observed a negative direct association of Openness with HR QoL in the current study. The positive association identified in prior research may be attributed to the tendency of open-minded individuals to be more creative, curious, and adaptable when facing life’s challenges [71]. Their greater emotional resilience, flexibility in addressing health issues, as well as willingness to explore novel approaches often facilitate the acquisition of positive support and other beneficial resources from their environment [72, 73]. Conversely, highly open individuals typically exhibit heightened self-awareness and sensitivity [74], which may increase their likelihood of perceiving or experiencing health issues [75]. In middle-aged and older adults with chronic diseases, such heightened awareness may translate into lower subjective evaluations of HR QoL compared with those who display other personality profiles. A study examining the relationship between personality traits and oral health-related quality of life also supports this negative association [74]. Furthermore, individuals with high levels of Openness, who tend to prioritize novel experiences and intellectual pursuits, may engage in activities that challenge established beliefs [72, 73] which may not always align with the structured and routine-oriented requirement of chronic disease management [76]. Future studies should further verify this finding using longitudinal designs, subgroup analyses by disease type and severity, and additional measures of illness perception, treatment burden, and functional limitation. Although the direct association of medication adherence with HR QoL was statistically significant, its magnitude was relatively small (β = 0.007), suggesting that adherence may be related to HR QoL primarily through indirect or cumulative associations rather than a direct association. This finding prompts us to re-examine its associations. It may indicate that in the complex process of chronic disease management, short-term medication behavior has limited direct impact on quality of life; its value is more likely realized through indirect and cumulative pathways. This is consistent with the viewpoints cited in the literature review that the value of adherence lies in its long-term impact on “disease control and progression” [13, 38]. Future studies should further verify this cumulative effect using longitudinal follow-up data, including repeated assessments of HR QoL, long-term clinical indicators of disease control, complication outcomes, functional status, and healthcare utilization measures such as hospitalizations and emergency department visits. In contrast, the core finding of this study, the sequential mediation pathway constituted by self-efficacy and medication adherence, offers a more robust description of the observed associations and provides novel insights into how personality traits are related to HR QoL through this sequential pathway. Previous research has indeed explored partial relationships among these variables; for instance, Du et al. [77] and Wu et al. [78] separately verified the mediating role of self-efficacy between personality traits and medication adherence. Our study theoretically expands this framework by integrating Social Cognitive Theory [35] and Self-Regulation Theory [36], and for the first time, empirically demonstrates a complete chain—from stable personality traits, to malleable core beliefs (self-efficacy), to specific health behaviors (medication adherence), and ultimately to health outcomes (HR QoL). This pathway helps to elucidate the triadic relationship within Social Cognitive Theory, wherein personality, as an intrinsic individual factor, interacts with behavioral factors and health outcomes, with self-efficacy serving as a key cognitive driver in this process. Our validation of the hypothesis testing results further supports this theoretical framework. Of particular note is the strong path coefficient between Conscientiousness and self-efficacy, which is theoretically sound. The organizational skills, sense of responsibility, and self-discipline inherent in conscientious individuals [5, 18] form the personality foundation for developing and maintaining high levels of self-efficacy—that is, the belief in one’s ability to manage chronic diseases [34, 37]. Consequently, while the strength of this path association is notably high, it does not indicate a lack of discriminant validity in the current predictive model; rather, it empirically reinforces the theoretical expectation that Conscientiousness serves as a key antecedent of self-efficacy. In summary, the model of this study reveals that personality is not primarily associated with HR QoL through weak direct associations. Instead, personality traits shape patients’ self-efficacy, which in turn drives the crucial health behaviors necessary for maintaining health. The consistent practice of these behaviors ultimately underpins better quality of life. This provides an actionable entry point for designing targeted interventions: by enhancing patients’ self-efficacy, we can activate the positive aspects of their personality, thereby improving their health behaviors and outcomes. Practical implications The findings of this study provide a refined framework for advancing personalized chronic disease management. Recognizing the influence of personality characteristics on health-related behaviors can inform the development of more individualized and theoretically grounded interventions. Although self-efficacy did not exert a strong direct effect on HR QoL in the present study, it remains a modifiable psychological resource that may indirectly influence well-being through behavioral regulation and coping processes. Programs designed to strengthen self-efficacy could help mitigate the detrimental impact of Neuroticism while leveraging the positive effects of Conscientiousness and Extraversion. Strategies to improve medication adherence should be guided by the “multiple distinct pathways” identified in this study, as the underlying causes of non-adherence may differ across individuals. Future efforts should focus on identifying these personality-based determinates more precisely to provide tailored support for patients with distinct personality profiles. Integrating brief personality assessments such as the BFI-10 into routine clinical practice may help identify high-risk patients and support more personalized, psychologically informed care. When time is limited, screening may focus on traits most relevant to chronic disease management, particularly lower Conscientiousness and higher Neuroticism. Limitations and future research directions A central limitation is the cross‑sectional design. The proposed serial mediation model is theoretically plausible and fits the observed covariance pattern well; nevertheless, longitudinal data are required to test whether self‑efficacy indeed precedes medication adherence and whether adherence precedes changes in HR QoL. Without such data, the temporal ordering implied by the model remains a theoretical assumption rather than an empirical conclusion. The proposed sequential pathway is theoretically plausible based on prior literature; however, given the cross-sectional design, our findings should be interpreted as evidence of statistical associations consistent with the model, not as proof of temporal ordering or causation. Furthermore, while the SEM fit indices were excellent, this only demonstrates that the model is statistically consistent with the data; it does not validate the proposed causal pathway or rule out alternative models with different directional assumptions. Self-report measures, though validated and anonymous, may introduce bias, and the brief personality scale limits assessment depth. The sample was not nationally representative, as it was drawn from chronic disease patients receiving medication. Importantly, excluding patients not prescribed medication or with incalculable adherence introduces selection bias, limiting generalizability to the broader chronic disease population (e.g., those not on medication, those who discontinued treatment, or those with milder disease not requiring pharmacotherapy). Future studies should use multiple data sources and more representative sampling. The medication adherence measure had modest reliability (Cronbach’sα = 0.68), which may cause conservative bias; future confirmatory studies should use longer scales and larger samples.We could not control for key clinical covariates, such as disease type, severity, duration, multimorbidity, medication burden (e.g., polypharmacy, dosage frequency, side effects), and cognitive status. These factors may confound the association between medication adherence and HR QoL, for instance, by directly influencing symptom burden, treatment complexity, or the patient’s ability to adhere reliably. Without adjusting for them, our estimates of the adherence–HR QoL link may be biased, and the strength of the sequential pathway could differ across clinical subgroups. Future research should incorporate these variables and trait-specific mechanisms (e.g., emotion regulation, coping) to refine the theoretical framework. Conclusion This study highlights the critical roles of self-efficacy and medication adherence in the relationship between personality traits and quality of life among middle-aged and older patients with chronic diseases. Supplementary Information Supplementary Material 1. Acknowledgements We would like to extend our sincere gratitude to Dr. Wu Yibo improve from the PBICR project team for his technical support rendered to this research. Abbreviations Health-Related Quality of Life Medication Adherence Rating Scale Authors’ contributions Jinyu He: Conceptualization, Methodology, Formal Analysis, Writing- Original draft preparation, Writing- Reviewing and Editing.Siyuan Liu: Formal Analysis, Writing- Original draft preparation, Writing- Reviewing and Editing.Yiran Wang: Writing- Reviewing and Editing.Huatang Zeng :Writing- Reviewing and Editing.Chenyu Yan: Conceptualization, Methodology, Formal Analysis, Funding acquisition, Supervision, Writing- Reviewing and Editing.Wannian Liang: Conceptualization, Methodology, Formal Analysis, Funding acquisition, Supervision, Writing- Reviewing and Editing. Funding This article is funded by the Research on the Management Mechanism of Major Chronic Disease Demonstration Areas project, with the project number 20235660072. Data availability This study has received data support from the PBICR project team, and the data sources are legal and valid. PBICR has not opened a public application channel. For a detailed introduction to this dataset, please visit: [https://m.x-mol.com/groups/pbicr/research.](https:/m.x-mol.com/groups/pbicr/research.) The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate Our study has been submitted to and approved by the local ethics committee or institutional review board (IRB). This study has passed the ethical reviews of the Shanxi Provincial Health Culture Research Center (JKWH-2021-01) and Jinan University (JNUKY-2021-018), and informed consent to participate in the study has been obtained from all participants. Competing interests The authors declare no competing interests. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Jinyu He and Siyuan Liu contributed equally to this work as first authors. Contributor Information Chenyu Yan, Email: yanchenyu@mail.tsinghua.edu.cn. Wannian Liang, Email: liangwn@mail.tsinghua.edu.cn. References Associated Data Supplementary Materials Supplementary Material 1. Data Availability Statement This study has received data support from the PBICR project team, and the data sources are legal and valid. PBICR has not opened a public application channel. For a detailed introduction to this dataset, please visit: [https://m.x-mol.com/groups/pbicr/research.](https:/m.x-mol.com/groups/pbicr/research.) The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.